129 related articles for article (PubMed ID: 14557015)
1. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma.
Pochylski T; Kwaśniewska A
Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):68-73. PubMed ID: 14557015
[TBL] [Abstract][Full Text] [Related]
2. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ; Landers RJ; Silva I; Uhlmann V; Crowley M; Healy I; Luttich K
J Clin Pathol; 1998 Aug; 51(8):576-82. PubMed ID: 9828814
[TBL] [Abstract][Full Text] [Related]
4. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions.
Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD
Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of H- and N-ras oncogenes in human cervical cancer.
Mammas IN; Zafiropoulos A; Koumantakis E; Sifakis S; Spandidos DA
Gynecol Oncol; 2004 Mar; 92(3):941-8. PubMed ID: 14984964
[TBL] [Abstract][Full Text] [Related]
6. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
7. Highly differentiated keratinizing squamous cell cancer of the cervix.
Rubinstein E
Am J Surg Pathol; 2002 May; 26(5):676; author reply 676. PubMed ID: 11979099
[No Abstract] [Full Text] [Related]
8. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction.
Aoyama C; Peters J; Senadheera S; Liu P; Shimada H
Diagn Mol Pathol; 1998 Dec; 7(6):324-30. PubMed ID: 10207671
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix.
Prokopakis P; Sourvinos G; Koumantaki Y; Koumantakis E; Spandidos DA
Oncol Rep; 2002; 9(1):129-33. PubMed ID: 11748470
[TBL] [Abstract][Full Text] [Related]
10. Highly differentiated keratinizing squamous cell cancer of the cervix: a rare, locally aggressive tumor not associated with human papillomavirus or squamous intraepithelial lesions.
Morrison C; Catania F; Wakely P; Nuovo GJ
Am J Surg Pathol; 2001 Oct; 25(10):1310-5. PubMed ID: 11688467
[TBL] [Abstract][Full Text] [Related]
11. Detection of HPV and ras gene mutations in cervical smears from female genital lesions.
Dokianakis DN; Sourvinos G; Sakkas S; Athanasiadou E; Spandidos DA
Oncol Rep; 1998; 5(5):1195-8. PubMed ID: 9683834
[TBL] [Abstract][Full Text] [Related]
12. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DNA mismatch repair system in cervical dysplasias and invasive carcinomas related to HPV infection.
Kwaśniewska A; Goździcka-Józefiak A; Postawski K; Miturski R
Eur J Gynaecol Oncol; 2002; 23(3):231-5. PubMed ID: 12094961
[TBL] [Abstract][Full Text] [Related]
14. K-ras expression--marker of dysplasia and cancer.
Bleotu C; Pleşa A; Botezatu A; Goia C; Drăguţel R; Socolov D; Corniţescu F; Teleman S; Anton G
Roum Arch Microbiol Immunol; 2009; 68(4):195-200. PubMed ID: 20583472
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) typing in relation to ras oncogene mRNA expression in HPV-associated human squamous cervical neoplasia.
Mammas IN; Zafiropoulos A; Sifakis S; Sourvinos G; Spandidos DA
Int J Biol Markers; 2005; 20(4):257-63. PubMed ID: 16398408
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears.
Dokianakis DN; Papaefthimiou M; Tsiveleka A; Spandidos DA
Oncol Rep; 1999; 6(6):1327-31. PubMed ID: 10523706
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.
Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP
Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus infection and Ki-ras oncogene in paraffin-embedded squamous carcinomas of the cervix.
Falcinelli C; Luzi P; Alberti P; Cosmi EV; Anceschi MM
Gynecol Obstet Invest; 1993; 36(3):185-8. PubMed ID: 8244195
[TBL] [Abstract][Full Text] [Related]
19. HPV infection and microsatellite instability in squamous lesions of the uterine cervix.
French D; Cermele C; Vecchione A; Cenci M; Vecchione A
Anticancer Res; 2000; 20(5B):3417-21. PubMed ID: 11131642
[TBL] [Abstract][Full Text] [Related]
20. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix.
Saegusa M; Takano Y; Hashimura M; Shoji Y; Okayasu I
Cancer; 1995 Dec; 76(11):2297-303. PubMed ID: 8635035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
